Next, we used western blotting to explore the expression of c‐Myc/P53 in the progression of AML compared with control group, and determined that c‐Myc was expressed at higher levels in AML specimens and cell lines, whereas P53 expression was inhibited (Figure 6A, B). This evidence concerns the gene MYC and acute myeloid leukemia.